Tyler Zeronda - Oct 2, 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Financial Officer
Signature
/s/ Mutya Harsch, attorney-in-fact for Tyler Zeronda
Stock symbol
VYNE
Transactions as of
Oct 2, 2023
Transactions value $
-$4,163
Form type
4
Date filed
10/4/2023, 04:26 PM
Previous filing
Jul 5, 2023
Next filing
Dec 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$4.16K -1.09K -13.56% $3.83 6.93K Oct 2, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.